In the BioHarmony Drug Report Database

"Preview" Icon

Elapegademase-lvlr

Revcovi (elapegademase) is an enzyme pharmaceutical. Elapegademase was first approved as Revcovi on 2018-10-05.

 

Trade Name

 

Revcovi
 

Common Name

 

elapegademase
 

ChEMBL ID

 

CHEMBL3990026
 

Indication

 

 

Drug Class

 

Enzymes; PEGylated compounds

Image (chem structure or protein)

Elapegademase-lvlr structure rendering